Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
burger-menu close-panel
🤝 We're Hiring! Apply now to join the Lozier Institute team
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Food and Drug Administration

Food and Drug Administration

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
9 results

Filter Results By

Filter Applied. Clear All

Latest Posts

December 20, 2024 Strengthening the Pro-Life Safety Net: Federal Transportation Policy Strengthening the Pro-Life Safety Net: Federal Transportation Policy December 19, 2024 End of Year Update: Tax Credits for Life Affirming Organizations End of Year Update: Tax Credits for Life Affirming Organizations December 19, 2024 Fact Sheet: Abortions at or after 15 Weeks in the United States Fact Sheet: Abortions at or after 15 Weeks in the United States
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

9 results
featured-image
Food and Drug Administration

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article in Issues in Law & Medicine arguing that decisions by the FDA to pull back regulations on the abortion drug mifepristone in part relied on "flawed studies with significantly undercounted complications" from the U.K.

Ingrid Skop, M.D., FACOG
May 23, 2024
Please login to bookmark Close
featured-image
Food and Drug Administration

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to remove medical safeguards and in-person administering of abortion drugs. These flaws illustrate the ongoing problem of lack of quality abortion reporting data in the U.S. as well as in the United Kingdom.

charlotte-lozier-institute Charlotte Lozier Institute
May 13, 2024
Please login to bookmark Close
Food and Drug Administration

Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data

The FDA’s abortion drugs complications data is woefully incomplete. From 2020-2022, the six states that report complications by type of procedure reported 1,004 total complications from drug-induced abortions. Meanwhile, the FDA Adverse Event Reporting System data reflects just 17 unduplicated abortion-related adverse events over this same period.

Tessa Cox Mia Steupert, M.A.
March 22, 2024
Please login to bookmark Close
Food and Drug Administration

Chemical Abortion: FDA Ignores ‘Inconvenient’ Science and Data Confirming Public Health Threat

The U.S. Food and Drug Administration (FDA) today announced plans to irresponsibly erode longstanding patient safeguards on the abortion pill, despite major U.S. and international research confirming that chemical abortion has led to a surge in emergency room visits and higher rates of complications.

charlotte-lozier-institute Charlotte Lozier Institute
December 16, 2021
Please login to bookmark Close
Food and Drug Administration

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk.

charlotte-lozier-institute Charlotte Lozier Institute
November 16, 2021
Please login to bookmark Close
featured-image
Food and Drug Administration

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Mary E. Harned, J.D.
August 19, 2020
Please login to bookmark Close
featured-image
Food and Drug Administration

News Release: Abortion Activist Sues FDA over Regulation of Dangerous Drugs 

Today Charlotte Lozier Institute released the following response to a lawsuit seeking to stop U.S. Food and Drug Administration enforcement of the regulation of dangerous abortion drugs shipped into the United States from overseas.

charlotte-lozier-institute Charlotte Lozier Institute
September 9, 2019
Please login to bookmark Close
featured-image
Food and Drug Administration

Bicameral Congressional Letter Demands Transparency from FDA

Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex.

Charles A. “Chuck” Donovan
April 26, 2016
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image